Radiation oncology firm Nucletron of Veenendaal, Netherlands, has received clearance from the U.S. Food and Drug Administration (FDA) for its volume-based treatment planning software.
Oncentra Brachy is DICOM-compatible and features optimization algorithms to shorten brachytherapy planning time. The software also offers 3D contouring and margining tools to identify regions of interest on CT or in multimodality imaging environments using image registration for CT, MR, and PET data.
Related Reading
Nucletron developing new brachytherapy technique, May 5, 2008
Nucletron debuts Oncentra Brachy, April 28, 2008
Nucletron debuts brachytherapy products, February 20, 2008
Nucletron appoints new executives, December 20, 2007
Nucletron spins off from Delft, September 13, 2007
Copyright © 2008 AuntMinnie.com
